AGENDA AT A GLANCE
8:50
IMAPAC’s Opening Address
Plenary Leadership Panel:
India’s Biologics & Vaccine Landscape - Market Trends, Public Health Priorities & Global Opportunities
9:00
Leadership Panel: Positioning India as a Global Biologics & Vaccine Innovation Hub
- Evolving market dynamics across biosimilars, vaccines and next-generation biologics.
- Advancing innovation through R&D, strategic partnerships, and translational science.
- Strengthening regulatory, clinical, and commercial readiness for global markets.
- Expanding equitable access while addressing national and global public health priorities.
Moderator:
Panelists:
10:05
Navigating the Future of India's Vaccine Ecosystem: Innovation, Investment & Global Competitiveness
- Exploring market trends shaping India's vaccine industry and global competitiveness.
- Driving innovation through strategic investments, policy support, and ecosystem collaboration.
- Strengthening India's position as a global hub for vaccine R&D, manufacturing, and supply resilience.
10:30
Morning Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Next-Generation Vaccine Platforms & Innovation
11:00
Advancing Next-Generation Vaccine Modalities Through Emerging Technologies and Scientific Innovation
- Advancing mRNA, saRNA, protein subunit, viral vector, and mucosal vaccine platforms.
- Optimizing manufacturing processes to improve speed, consistency, and cost efficiency.
- Strengthening technology transfer and scalable production for future vaccine pipelines.
11:25
Supporting the Commercialization of Next-Generation Vaccines Through Integrated Manufacturing and Process Innovation
- Scaling manufacturing for emerging vaccine modalities with flexible and platform-based production.
- Enhancing process development, technology transfer, and quality systems for efficient commercialization.
- Building resilient manufacturing infrastructure to strengthen global vaccine supply and pandemic preparedness.
11:40
Advancing Next-Generation Vaccine Delivery Systems for Improved Protection and Accessibility
- Exploring innovative delivery technologies, including needle-free, intranasal, oral, and microneedle-based vaccines.
- Improving vaccine stability, patient acceptance, and immunization coverage through novel delivery approaches.
- Accelerating the translation of innovative delivery technologies into clinical practice.
12:05
Unlocking the Potential of Novel Adjuvants and Immunoengineering in Next-Generation Vaccines
- Enhancing vaccine efficacy through innovative adjuvant technologies.
- Improving immune responses for challenging infectious diseases.
- Accelerating the development of durable and broad-spectrum vaccine protection.
12:30
Lunch Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Preventive Vaccines: Advancements in Disease Prevention and Immunization Strategies
2:00
Fireside chat: Building Resilient Vaccine Supply Chains in an Era of Global Uncertainty
- Lessons learned from recent global supply chain disruptions.
- Balancing local manufacturing with global distribution networks.
- Preparing supply chains for future public health emergencies.
Moderator:
Panelists:
2:30
Transforming Immunization Programmes Through Digital Health, Data & Vaccine Intelligence
- Using digital technologies to improve immunization planning, coverage, and programme performance.
- Leveraging data analytics and disease surveillance to support evidence-based vaccination strategies.
- Enhancing collaboration across healthcare systems to strengthen preventive immunization outcomes.
2:45
Advancing Dengue Prevention: Next-Generation Vaccines, Surveillance & Immunization Strategies
- Addressing the growing dengue burden through next-generation vaccination strategies and integrated public health approaches.
- The evolving role of dengue vaccines alongside surveillance, vector control, and outbreak preparedness.
- Accelerating equitable access, policy adoption, and implementation of dengue immunization programmes in endemic regions.
3:10
Strengthening India's Disease Prevention Strategy Through Preventive Vaccination
- Addressing India's evolving infectious disease landscape through vaccination.
- Enhancing collaboration between government, industry, and public health stakeholders.
- Expanding access to preventive vaccines to improve population health outcomes.
3:35
Afternoon Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Development of Vaccines for Emerging Diseases
Accelerating Vaccine Research for New Threats
4:05
Preparing for Disease X: Accelerating Vaccine Development for Emerging Infectious Threats
- Strengthening India's preparedness for emerging and re-emerging infectious diseases.
- Advancing collaborative R&D, surveillance, and rapid-response vaccine development.
- Enhancing partnerships across government, academia, industry, and global health organizations to improve outbreak preparedness.
4:30
Accelerating Vaccine Research for Emerging Diseases Through AI, Genomics & Advanced Research Technologies
- Leveraging AI, genomics, and bioinformatics to accelerate vaccine discovery.
- Supporting rapid antigen identification and translational vaccine research.
- Enabling collaborative research ecosystems to shorten vaccine development timelines
4:45
Enabling Rapid Vaccine Development for Emerging Diseases Through Flexible Manufacturing & Platform Technologies
- Accelerating scale-up using platform technologies and flexible manufacturing.
- Supporting rapid technology transfer and process development for outbreak response.
- Building resilient manufacturing capabilities to strengthen pandemic preparedness.
5:10
Chairman Closing Remarks
5:10
End of Conference - Day 1 | Cocktails & Networking
6:00
8:50
IMAPAC’s Opening Address
8:55
Chairman’s Opening Address
Breakthroughs in Vaccine Technologies
The Role of mRNA Platforms
9:00
Unlocking the Full Potential of mRNA Platforms: From Pandemic Response to Broad-Spectrum Disease Prevention
- Expanding mRNA applications beyond COVID-19 into infectious diseases and therapeutic vaccines.
- Addressing manufacturing, stability, and delivery challenges for mRNA vaccines.
- Accelerating global collaboration to advance mRNA innovation and commercialization.
9:25
Panel Discussion: The Future of Vaccine Innovation – Are Next-Generation Technologies Ready to Transform Global Immunization?
- Evaluating the readiness of mRNA, saRNA, circular RNA, viral vector, and protein-based vaccine platforms.
- Overcoming scientific, regulatory, and manufacturing challenges for widespread adoption.
- Building collaborations to accelerate the translation of breakthrough technologies into public health impact.
Moderator:
Panelists:
Scaling Up Vaccine Manufacturing
New-Age Automations & Advanced Technologies
10:20
Advancing Vaccine Manufacturing Through Next-Generation Quality Systems and Advanced Processing Technologies
- Strengthening quality-by-design (QbD), process analytical technology (PAT), and continuous manufacturing.
- Integrating advanced analytics to improve product consistency and regulatory readiness.
- Enhancing manufacturing excellence through innovative quality and process technologies.
10:35
Morning Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee
11:15
Accelerating Commercial Vaccine Manufacturing: Strategies for Scale, Speed & Supply Resilience
- Scaling production capacity while maintaining product quality and regulatory compliance.
- Improving manufacturing agility to respond to changing global vaccine demand.
- Strengthening resilient production networks to support pandemic preparedness.
11:40
11:55
Transforming Vaccine Manufacturing Through Smart Automation, AI & Digital Factory Solutions
- Leveraging AI, robotics, IoT, and digital manufacturing technologies to improve operational efficiency.
- Enabling real-time process monitoring and data-driven manufacturing decisions.
- Building intelligent manufacturing facilities to improve productivity and flexibility.
12:20
Lunch Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Vaccine Supply Chain & Distribution Strategy
2:00
Fireside chat: Building Resilient Vaccine Supply Chains in an Era of Global Uncertainty
- Lessons learned from recent global supply chain disruptions.
- Balancing local manufacturing with global distribution networks.
- Preparing supply chains for future public health emergencies.
2:30
Transforming Vaccine Supply Chains Through Digitalization, AI & End-to-End Visibility
- Using AI, IoT, and digital platforms to improve supply chain planning and execution.
- Enhancing traceability, inventory optimization, and predictive decision-making.
- Building connected supply chain ecosystems to improve operational efficiency.
2:45
Improving Vaccine Access Through Innovative Distribution Models and Public–Private Collaboration
- Strengthening last-mile delivery in urban, rural, and underserved communities.
- Building partnerships to improve equitable vaccine access and distribution.
- Addressing infrastructure and operational challenges across diverse healthcare settings.
3:10
Future-Proofing Vaccine Supply Networks Through Risk Management and Strategic Partnerships
- Managing supply chain disruptions through proactive risk mitigation.
- Diversifying sourcing and strengthening regional manufacturing networks.
- Building agile supply chains to support future pandemic preparedness.
3:35
Afternoon Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Plenary Closing Panel: Building India's Next-Generation Biologics Ecosystem
Accelerating Collaboration, Innovation & Commercial Success
4:05
Strategic Outlook Panel: Enabling a Collaborative Biologics Ecosystem for Sustainable Growth and Global Impact
- Cross-sector collaboration driving the next wave of biologics innovation
- CDMO, biotech and pharma partnerships deepening across the ecosystem
- Talent development building the industry’s future leadership pipeline
- Digital culture accelerating innovation and collaboration across teams
4:50
Chairman Closing Remarks
5:00
End of Conference
CONTACT
Anusha Shirshyad, Conference Producer
anusha.shirshyad@imapac.com
+65 6964 5109
